| Suspended | Clinical Study of Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) | Phase 1 | 2014-06-01 |
| Completed | Study to Determine the Safety, Tolerability, Pharmacokinetics, Food Effect and Pharmacodynamics of Single and Healthy | Phase 1 | 2013-08-01 |
| Suspended | Study of an Oral Cdk Inhibitor Administered With an Oral BRAF Inhibitor in Patients With Advanced or Inoperabl Advanced or Inoperable Malignant Melanoma With BRAF Mutation | Phase 1 | 2013-08-01 |
| Unknown | Determination of Safety,Tolerability,Pharmacokinetics,Food Effect& Pharmacodynamics of Single & Multiple Doses Overweight, Diabetes Mellitus Type 2 in Obese | Phase 1 | 2013-06-01 |
| Suspended | Clinical Study of Oral IGF-1R Inhibitor in Subjects With Advanced Refractory Solid Tumors Advanced Refractory Solid Tumors | Phase 1 | 2012-12-01 |
| Suspended | Clinical Study of Oral PI3K/mTOR Inhibitor in Patients With Advanced Refractory Solid Tumors Advanced Refractory Solid Tumors | Phase 1 | 2012-09-01 |
| Completed | A Study to Assess Radiation Induced Mucositis in Patients of Head and Neck Cancer Administered Chemo-Radiation Radiation Induced Mucositis in Head and Neck Cancer | Phase 2 | 2012-07-01 |
| Terminated | Clinical Trial to Study the Safety Tolerability, Pharmacokinetics, Food Effect & Pharmacodynamics of a New Com Healthy, Overweight and/or Obese Subjects | Phase 1 | 2012-05-01 |
| Terminated | A Clinical Trial Comparing Gemcitabine and Carboplatin With and Without P276-00 in Subjects With Metastatic Tr Breast Cancer | Phase 1 | 2011-08-01 |
| Terminated | Study of P3914 to Evaluate the Safety, Tolerability, Food Effect & Pharmacokinetics in Healthy Male Subjects a Acute Dental Pain | Phase 1 | 2011-06-01 |
| Terminated | A Clinical Trial to Study the Efficacy, Safety, Tolerability and Pharmacokinetics of P2202 in Patients of Type Type 2 Diabetes Mellitus | Phase 2 | 2011-04-01 |
| Completed | A Phase IV Clinical Trial to Study the Safety, Tolerability and Efficacy of Tinefcon in Patients With Plaque P Plaque Psoriasis | Phase 4 | 2010-12-01 |
| Terminated | A Phase II Study to Evaluate Efficacy and Safety of P276-00 in Relapsed and/or Refractory Mantle Cell Lymphoma Mantle Cell Lymphoma | Phase 2 | 2009-11-01 |
| Completed | Safety and Efficacy Study of P276-00 in Combination With Radiation in Subjects With Advanced Head and Neck Can Squamous Cell Carcinoma of Head and Neck | Phase 1 / Phase 2 | 2009-08-01 |
| Completed | Safety and Efficacy Study of P276-00 in Combination With Gemcitabine in Patients With Advanced Pancreatic Canc Pancreatic Cancer | Phase 1 / Phase 2 | 2009-05-01 |
| Completed | Efficacy Study Of P276-00 In Subjects Of Malignant Melanoma Positive For Cyclin D1 Expression Melanoma | Phase 2 | 2009-05-01 |
| Completed | A Study Of Selective Cyclin Dependent Kinase Inhibitor P1446A-05 In Subjects With Advanced Refractory Malignan Solid Tumor, Hematologic Malignancy | Phase 1 | 2008-12-01 |
| Withdrawn | Phase I Study for Safety and Efficacy of P276-00 in Subjects With Myeloma Multiple Myeloma | Phase 1 | 2008-12-01 |
| Completed | A Multicenter Phase I Clinical Study of a New Compound P1446A-05 in Patients With Advanced Refractory Malignan Cancer | Phase 1 | 2008-12-01 |
| Completed | A Phase II Clinical Trial to Study the Efficacy and Safety of a New Drug P276-00 in Treatment of Recurrent and Squamous Cell Carcinoma of Head and Neck | Phase 2 | 2008-09-01 |
| Completed | Study To Evaluate Safety and Efficacy of P276-00 in Subjects With Refractory Multiple Myeloma Relapsed and/or Refractory Multiple Myeloma | Phase 1 / Phase 2 | 2008-01-01 |
| Terminated | Phase I Study of P276-00 in Patients With Advanced Refractory Neoplasms Neoplasm | Phase 1 | 2006-03-01 |
| Completed | Open Label Phase I Study of P276-00 in Patients With Advanced Refractory Neoplasms Neoplasm | Phase 1 | 2005-05-01 |